Keywords
How to Cite
Abstract
The article presents data about the cardiovascular risk factors in patients on treatment with programmed hemodyalisis taking into the account the presence of type II diabetes mellitus. It was estimated that patients suffering on chronic kidney disease have high and extremely high levels of cardiovascular risk. The presence of type II diabetes mellitus significantly increases the level of cardiovascular risk. The important component of complex cardiovascular risk reduction measures is a strong control under the blood glucose, calcium and phosphorus concentrations in the serum.
References
Ефремова, ОА, Головин АИ, Ходыкина ЮЕ. Особенности фосфорно-кальциевого обмена у больных, находящихся на лечении программным гемодиализом. Научный результат. Сер. Медицина и фармация. 2016;2(4):24-9. DOI: 10.18413/2313-8955-2016-2-4-24-29.
Lee WC, Lee YT, Li LC, Ng HY, Kuo WH, Lin PT et al. The Number of Comorbidities Predicts Renal Outcomes in Patients with Stage 3–5 Chronic Kidney Disease. J Clin Med. 2018 Dec;7(12):493. DOI:10.3390/jcm7120493.
Genovesi S, Boriani G, Covic A, Vernooij RWM, Combe C, Burlacu A et al. Sudden cardiac death in dialysis patients: different causes and management strategies. Nephrology Dialysis Transplantation. 2021;3(36):396–405.
Kramer А, Pippias М, Vianda S, Bonthuis М, Diez JMA, Afentakis N. еt аl. Renal replacement therapy in Europe: a summary of the 2013 ERA-EDTA registry annual report with a focus on diabetes mellitus. Clin. Kidney J. 2016;3(9):457–69. DOI: 10.1093/ckj/sfv151.
Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJL, Mann JF et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013 Jul;382(9889):339–52. DOI:10.1016/S0140–6736(13)60595–4.
American Diabetes Association. Microvascular complications and footcare. Standards of medical care in diabetes — 2020. Diabetes Care.2020 Jan;1(43):135-151. DOI:10.2337/dc20-S011.
Сердечно-сосудистый риск и хроническая болезнь почек: стратегии кардио-нефропротекции. Российский кардиологический журнал. 2014;8(112):7-37.
Bulbul MC, Dagel T, Afsar B, Ulusu NN, Kuwabara M, Covic A, et al. Disorders of Lipid Metabolism in Chronic Kidney Disease. Blood Purification. 2018;2(46):144-152. DOI: 10.1159/000488816.
Zhan X, Yang M, Chen Y, Zhang L, Yan C, Wang Y. Comparison of risk of stroke in patients treated with peritoneal dialysis and hemodialysis: a systematic review and meta-analysis. Ren Fail. 2019;1(41):650–656. DOI:10.1080/0886022X.2019.1632210
Steinvil M, Banai S, Leshem-Rubinow E. The development of anemia of inflammation during acute myocardial infarction. International J. Cardiol. 2012;2(156):160–4. DOI:10.1016/j.ijcard.2010.10.031.